Acadia Healthcare falls after Raymond James downgrade
Shares were down 1.6% at $27.64 after Raymond James downgraded ACHC to "outperform" from "strong buy". The brokerage kept its price target unchanged at $39; the median broker target was $32.5.
Shares were down 1.6% at $27.64 after Raymond James downgraded ACHC to "outperform" from "strong buy". The brokerage kept its price target unchanged at $39; the median broker target was $32.5.